Showing 171-180 of 9140 results for "".
DermWireTV: Sotyktu Approval, Cetaphil at 75, Psoriasis/Depression Link
https://practicaldermatology.com/topics/psoriasis/dermwiretv-sotyktu-approval-cetaphil-at-75-psoriasisdepression-link/20138/FDA has approved Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the oral treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. April Armstrong, MD discusses the first TYK-2 inhibitor approved for psoriasis. As Cetaphil (Galderma)The Role of Inflammation in Acne Vulgaris
https://practicaldermatology.com/topics/general-topics/the-role-of-inflammation-in-acne-vulgaris/21512/Multiple lines of evidence support a pivotal role for inflammation in the pathogenesis of acne vulgaris.Colloidal Oatmeal in the Treatment of Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/colloidal-oatmeal-in-the-treatment-of-atopic-dermatitis/23338/Is this plant-based intervention an effective treatment alternative?Eradicating the Itch of Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/eradicating-the-itch-of-atopic-dermatitis/23947/Emerging treatments explore alternative pathways to stop itching at the source.Neurotoxin Tips for Beginners and Advanced Users
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/neurotoxin-tips-for-beginners-and-advanced-users/21578/Experts from the international aesthetics arena share pearls for maximizing neurotoxins.Adjusting to a Paradigm Shift in Documentation
https://practicaldermatology.com/topics/practice-management/adjusting-to-a-paradigm-shift-in-documentation/21681/Clinicians can navigate changing rules by selecting technologies that accommodate rapid shifts in documentation.A Growing Biologics Armamentarium for Psoriasis and Atopic Dermatitis
https://practicaldermatology.com/topics/psoriasis/a-growing-biologics-armamentarium-for-psoriasis-and-atopic-dermatitis/20660/An overview of effective and safe treatment options that continue to come to market to target these chronic conditions.New Directions in Acne Care
https://practicaldermatology.com/topics/acne-rosacea/new-directions-in-acne-care/23515/Recent developments and therapeutic advancements continue to improve outcomes in the management of this common, inflammatory disease.Therapeutics Update: Notable Approvals in 2017
https://practicaldermatology.com/topics/skin-cancer-photoprotection/therapeutics-update-notable-approvals-in-2017/20398/A look at the newest additions to the medicine chest.A Practical Approach: Field Treatment of AKs with PDT
https://practicaldermatology.com/issues/supplements/a-practical-approach-field-treatment-of-aks-with-pdt/20431/Why it's essential to treat visible and invisible actinic keratosis lesions and how PDT fits into the treatment armamentarium.